GPX4 and cancer: Besides, Mannes et al. pointed out that even a minute level of GPX4 expression was sufficient for therapy-resistant cancer cells to survive, suggesting that only partial inhibition of the expressions of GPX4 and FSP1 might not be enough to kill CSCs in some cancers (Mannes et al., 2011).